InDuo®, a novel combined insulin injection and blood glucose monitoring device - Effective and save as other devices, and patient preference

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 9, 2005, Pages 541-544

  Haupt, A ^a   Berg, B ^d   Paschen, P ^b   Dreyer, M ^c   Haring H U ^a   Smedegaard, J ^d   Skovlund, S E ^d   Matthaei, S ^e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Diabetologische Schwerpunktpraxis   (Germany)

^c Krankenhaus Bethanien   (Germany)

^d NOVO NORDISK A S   (Denmark)

^e Quakenbrück Hospital   (Germany)

Author keywords

Blood glucose monitoring devices; Diabetes; InDuo ; Patient preference

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; HUMINSULIN BASAL; INSULIN; INSULIN ASPART; INSULIN LISPRO; ISOPHANE INSULIN; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INSULIN INFUSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGED; BLOOD; COMPARATIVE STUDY; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 27744515459     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865928     Document Type: Article

References (13)

1. American Diabètes Association. Self-monitoring of blood glucose. Diabetes Care 1994; 17: 81-86
2. Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care 1986; 9: 168-172
3. Bennion N, Christensen NK, McGarraugh G. Alternate site glucose testing: A crossover design. Diabetes Technol Ther 2002; 4: 25-33
4. Carley SD et al. An open prospective randomized trial to reduce the pain of blood glucose testing: ear versus thumb. BMJ 2000; 321: 7252
5. Cohen M. Earlobes are less convenient than fingerpricks for blood glucose testing. BMJ 2000; 321: 1161
6. Evans JM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ 1999; 319: 83-86
7. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B, ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-594
8. Harris MI et al. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993; 16: 1116-1123
9. Loveland ME et al. Assessment of the pain of blood sugar testing: a randomized controlled trial. Lancet 1999; 354: 921-922
10. Rodin J, Salvoy P. Health psychology. Annu Rev Psychol 1989; 40: 533-579
11. Sarol JN Jr, Nicodemus NA Jr, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 2005; 21: 173-184
12. Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med 2004; 164: 645-652
13. Tiezen KL, New JP. Alternative site blood glucose testing: do patients prefer it. Diabetic Medicine 2003; 20: 325-328